ATE151283T1 - Arzneimittel mit kontrollierter wirkstoffabgabe - Google Patents

Arzneimittel mit kontrollierter wirkstoffabgabe

Info

Publication number
ATE151283T1
ATE151283T1 AT92902527T AT92902527T ATE151283T1 AT E151283 T1 ATE151283 T1 AT E151283T1 AT 92902527 T AT92902527 T AT 92902527T AT 92902527 T AT92902527 T AT 92902527T AT E151283 T1 ATE151283 T1 AT E151283T1
Authority
AT
Austria
Prior art keywords
active ingredients
controlled delivery
medicinal products
core
vinylpyrrolidine
Prior art date
Application number
AT92902527T
Other languages
English (en)
Inventor
John Michael Newton
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Application granted granted Critical
Publication of ATE151283T1 publication Critical patent/ATE151283T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Lubricants (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Glass Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92902527T 1990-11-22 1991-11-21 Arzneimittel mit kontrollierter wirkstoffabgabe ATE151283T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909025372A GB9025372D0 (en) 1990-11-22 1990-11-22 Pharmaceutical dosage forms
PCT/GB1991/002057 WO1992009270A1 (en) 1990-11-22 1991-11-21 Controlled release compositions

Publications (1)

Publication Number Publication Date
ATE151283T1 true ATE151283T1 (de) 1997-04-15

Family

ID=10685781

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92902527T ATE151283T1 (de) 1990-11-22 1991-11-21 Arzneimittel mit kontrollierter wirkstoffabgabe

Country Status (14)

Country Link
EP (1) EP0559813B1 (de)
JP (1) JPH06502636A (de)
KR (1) KR930701984A (de)
AT (1) ATE151283T1 (de)
AU (1) AU653372B2 (de)
CA (1) CA2096733A1 (de)
DE (1) DE69125619T2 (de)
ES (1) ES2101082T3 (de)
FI (1) FI932320A7 (de)
GB (2) GB9025372D0 (de)
HU (1) HUT65756A (de)
NO (1) NO931859L (de)
WO (1) WO1992009270A1 (de)
ZA (1) ZA919185B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2089498T3 (es) * 1991-01-30 1996-10-01 Wellcome Found Comprimidos dispersables en agua.
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
TW246635B (de) * 1992-10-08 1995-05-01 Shell Internat Res Schappej B V
DK66493D0 (da) * 1993-06-08 1993-06-08 Ferring A S Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US6028190A (en) 1994-02-01 2000-02-22 The Regents Of The University Of California Probes labeled with energy transfer coupled dyes
US6166024A (en) 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
HRP970485A2 (en) * 1996-09-13 1998-08-31 Joerg Rosenberg Process for producing solid pharmaceutical forms
DE19649100A1 (de) * 1996-11-27 1998-06-04 Lohmann Therapie Syst Lts Verfahren zur verlustarmen Herstellung wirkstoffhaltiger scheibenförmiger Formkörper und diese enthaltende transdermale therapeutische Systeme
DE69917618T2 (de) 1998-04-03 2005-06-23 Egalet A/S Zusammensetzung mit kontrollierter wirkstoff-freisetzung
DE19840256A1 (de) 1998-09-03 2000-03-09 Basf Ag Verfahren zur Herstellung von beschichteten festen Dosierungsformen
PT1146862E (pt) 1999-01-29 2003-09-30 Disphar Int Bv Composicoes farmaceuticas
WO2002005788A1 (en) * 2000-07-14 2002-01-24 Universiteit Gent Composite solid shaped articles for the controlled delivery of biologically active ingredients
WO2003024430A1 (en) 2001-09-21 2003-03-27 Egalet A/S Morphine polymer release system
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
US20030203027A1 (en) * 2002-04-26 2003-10-30 Ethicon, Inc. Coating technique for deposition of drug substance on a substrate
KR20100120243A (ko) * 2002-05-07 2010-11-12 피시비다 유에스 인코포레이티드 약물 전달 장치를 형성하는 공정
GB0214013D0 (en) 2002-06-18 2002-07-31 Euro Celtique Sa Pharmaceutical product
EP1562552A1 (de) 2002-11-08 2005-08-17 Egalet A/S Zusammensetzung zur kontrollierten wirkstoffabgabe von carvedilol
ES2360102T3 (es) 2003-03-26 2011-05-31 Egalet A/S Sistema para la liberación controlada de morfina.
EP1974726B1 (de) 2003-03-26 2010-01-13 Egalet A/S Matrixzubereitungen für die kontrollierte Darreichung von Arzneistoffen
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
WO2008148798A2 (en) 2007-06-04 2008-12-11 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
NZ594207A (en) 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
AU2010265213B2 (en) 2009-06-24 2012-08-23 Egalet Ltd. Controlled release formulations
US20130108697A1 (en) * 2010-03-04 2013-05-02 Ramakant Kashinath Gundo Modified release dosage form
BR112015000150A2 (pt) 2012-07-06 2017-06-27 Egalet Ltd composições farmacêuticas dissuasoras de abuso de liberação controlada
EP3522825B1 (de) * 2016-10-05 2023-06-07 Titan Pharmaceuticals, Inc. Implantierbare vorrichtungen zur arzneimittelabgabe mit reduzierter burst-freisetzung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
GB2170104A (en) * 1985-01-30 1986-07-30 Warner Lambert Co Coated pharmaceutical dosage forms
IE861284L (en) * 1986-05-14 1987-11-14 Birex Res And Dev Ltd And Carm Controlled release ketoprofen.
US4810501A (en) * 1986-06-17 1989-03-07 Warner-Lambert Company Sustained release pharmaceutical preparations
GB8618811D0 (en) * 1986-08-01 1986-09-10 Approved Prescription Services Sustained release ibuprofen formulation
US5158881A (en) * 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments

Also Published As

Publication number Publication date
DE69125619D1 (de) 1997-05-15
CA2096733A1 (en) 1992-05-23
ZA919185B (en) 1992-09-30
FI932320L (fi) 1993-07-09
GB2249957B (en) 1994-11-23
EP0559813B1 (de) 1997-04-09
AU653372B2 (en) 1994-09-29
HU9301499D0 (en) 1993-09-28
DE69125619T2 (de) 1997-09-11
GB9025372D0 (en) 1991-01-09
GB9124776D0 (en) 1992-01-15
ES2101082T3 (es) 1997-07-01
GB2249957A (en) 1992-05-27
FI932320A0 (fi) 1993-05-21
JPH06502636A (ja) 1994-03-24
NO931859L (no) 1993-07-21
NO931859D0 (no) 1993-05-21
HUT65756A (en) 1994-07-28
FI932320A7 (fi) 1993-07-09
AU8909691A (en) 1992-06-25
WO1992009270A1 (en) 1992-06-11
EP0559813A1 (de) 1993-09-15
KR930701984A (ko) 1993-09-08

Similar Documents

Publication Publication Date Title
ATE151283T1 (de) Arzneimittel mit kontrollierter wirkstoffabgabe
CA2376226A1 (en) New formulation
FI853934L (fi) Doseringssystem som bestaor av flera enheter och har en belaeggning som tillaoter diffusion.
DE69109557D1 (de) Überzogene feste Arzneiform mit Verabreichungsmöglichkeit im Dickdarm.
ATE287260T1 (de) Formulierung mit einer vorgeformten öffnung zur gesteuerten freisetzung
DE69023896D1 (de) Zementhilfsmittel, dessen herstellung sowie zementzusammensetzung.
ATE201989T1 (de) Arzneimittel mit kontrollierter wirkstoffabgabe
ATE151285T1 (de) Orale arzneimittel mit kolonspezifischer freisetzung
DE69004214D1 (de) Arzneimittel mit verzögerter freisetzung und ph-gesteuerten membranüberzügen.
DE69636223D1 (de) Formulierung mit gesteuerter freisetzung für wasserlöslische arzneistoffe, in der eine auslauföffnung in situ gebildet wird
ATE269709T1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
AP2001002237A0 (en) Hydrogel-driven drug dosage form.
DE69909316D1 (de) Pharmazeutische formulierung mit omeprazol
AP9100285A0 (en) Substituted benzimidazoles,process for their preparation and their pharmaceutical use
AR009696A2 (es) Dispositivo inhalador para administrar un polvo seco medicamentoso, procedimiento para su realizacion y envase de burbujas para ser usado con dicho dispositivo.
FI964253A0 (fi) Kollageenivalmiste vaikuttavien aineiden säädellyksi vapauttamiseksi
EP0230264A3 (en) Pharmaceutical composition for nasal application, process for its preparation and its use
ES2060293T3 (es) Nueva sustancia antiulcerosa.
DE3877365D1 (de) Arzneimittel mit methylcellulose.
ATE139694T1 (de) Arzneimittel
MX9202536A (es) Antibioticos tetraciclicos y procedimiento para su preparacion.
ATE206911T1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff
IS1914B (is) Ný LH-RH mótlyf, framleiðsla þeirra og notkun, ásamt læknislyfjum sem innihalda samsetningarnar og framleiðsla þeirra
DE3772954D1 (de) Arzneimittel mit verzoegerter wirkstoffabgabe.
FI930378A0 (fi) Fosfenoxidavslutade allen-en-yn dna-spjaelkande, antitumoer och antibiotika molekyler

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties